Halozyme Therapeutics (HALO) Tops Q3 EPS by 31c, provides guidance
Go back to Halozyme Therapeutics (HALO) Tops Q3 EPS by 31c, provides guidance| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 69.47 -1.26 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.73 | 52 Week High | $18.39 | |||
| Open | $71.01 | 52 Week Low | $6.96 | |||
| Day High | $71.81 | P/E | N/A | |||
| Day Low | $69.33 | EPS | $-0.58 | |||
| Volume | 299,500 | |||||
